Clinical Trial Update: Evaluation of Salivary Adseverin, 1-Alpha Defensin and sRANKL Levels of Individuals With Different Periodontal Diseases [NA]

View source ↗

Summary

Completed clinical study evaluating salivary biomarkers including adseverin, alpha-defensin, and sRANKL across different periodontal diseases.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Periodontal Diseases

Snippet

Sponsor: Izmir Katip Celebi University | Conditions: Periodontal Diseases | NA | Status: COMPLETED